Form ARS CIRRUS LOGIC, INC. For: Mar 28
Tweet
Share
E-mailATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Antengene Announces Exclusive License Agreement with MPM BioImpact-Established K2 Therapeutics for ATG-106 and Option for Undisclosed Bispecific TCE
- Acorn Acquires B Online Learning to Close the Gap Between Learning Investment and Workforce Readiness
- LOTTE Biologics Completes Construction of Songdo Bio Campus Plant 1 and Obtains Approval for Use
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
